ClassID:

2189

A01K2217/15 - page 3 - CPC Classification

Classification description:

Genetically modified animals Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding

Recent Application in this class:
#601
20100122358
2010-05-13

H-Chain-only antibodies

#602
20100115640
2010-05-06

Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells

#603
20100105043
2010-04-29

METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION

#604
20100077491
2010-03-25

Modulators of RNF5 and Uses Thereof

#605
20100069614
2010-03-18

Antibody producing non-human mammals

#606
20100050276
2010-02-25

Transgenic non-human animal models of apoptosis-mediated conditions

#607
20090324585
2009-12-31

COMPLEMENT INHIBITORY AGENTS AS THERAPEUTICS IN POSTTRAUMATIC AND DEGENERATIVE ARTHRITIS

#608
20090305987
2009-12-10

Method For Inducing Beta Cell Neogenesis From Epithelial Cells

#609
20090293139
2009-11-26

DOUBLE-INDUCIBLE GENE ACTIVATION SYSTEM AND ITS APPLICATIONS

#610
20090271884
2009-10-29

ES Cell-Derived Mice From Diploid Host Embryo Injection

#611
20090241203
2009-09-24

Transgenic porcine models of cystic fibrosis

#612
20090235369
2009-09-17

Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof

#613
20090235368
2009-09-17

Method of identifying compounds using a transgenic pig model of cystic fibrosis

#614
20090205059
2009-08-13

Methods, compositions and systems for production of recombinant spider silk polypeptides

#615
20090193533
2009-07-30

Conditional-stop dimerizable caspase transgenic animals

#616
20090098115
2009-04-16

Cell lines and animal models of HER2 expressing tumors

#617
20090081128
2009-03-26

Model of Alzheimer's Disease

#618
20080317743
2008-12-25

Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

#619
20080289053
2008-11-20

Methods and systems for identifying modulators of longevity

#620
20080274914
2008-11-06

Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3

#621
20080242742
2008-10-02

Animal models of pancreatic adenocarcinoma and uses therefor

#622
20080196110
2008-08-14

Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)

#623
20080194472
2008-08-14

Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation

#624
20080194457
2008-08-14

Frizzled proteins and detection and treatment of cancer

#625
20080184378
2008-07-31

Non human animals with human-glial chimeric brains

#626
20070237787
2007-10-11

Methods for use of TSLP and agonists and antagonists thereof

#627
20060174363
2006-08-03

Germline transmission of avian primordial germ cells (PGCs)

#628
20060174362
2006-08-03

Long-term culture of avian primordial germ cells (PGCs)

#629
20060161995
2006-07-20

Artificial human chromosome containing human antibody a light chain gene

#630
20060037093
2006-02-16

Transgenic transchromosomal rodents for making human antibodies

#631
20060026698
2006-02-02

Transgenic transchromosomal rodents for making human antibodies

#632
20060015958
2006-01-19

Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission

#633
20060008455
2006-01-12

Methods and compositions for using aleveolar macrophage phospholipase A2

#634
20050281803
2005-12-22

Methods and compositions for using alveolar macrophage phospholipase A2

#635
20050249712
2005-11-10

Methods for use of TSLP and agonists and antagonists thereof

#636
15257587
2022-05-17

PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis